Drugs / Pabrinex
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03466528 Comparator | Dec 2016 → Apr 2018 | Wernicke encephalopathy, alcohol withdrawal, lactic acidosis, magnesium deficiency +1 | Glasgow Royal Infirmary | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pabrinex | “Thiamine will be administered as IV Pabrinex, a compound preparation which also contains B vitamins and vitamin C.” NCT03466528 ↗ |
| Route | Intravenous | “Thiamine will be administered as IV Pabrinex, a compound preparation which also contains B vitamins and vitamin C.” NCT03466528 ↗ |